drugset / Trial / NCT05985278

Clinical Application of Lutetium [177Lu]-Catalase in Tumor Radionuclide Therapy

NCT05985278 ↗

Phase 0 Unknown 10 enrolled Peking University Cancer Hospital & Institute
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the retention in tumour and distribution behavior of \[Lu-177\]-Catalase after intratumoral injection,and preliminary evaluation the efficacy and safety of \[Lu-177\]-Catalase.

Timeline

Start
2023-07-06
Primary completion
2026-06-15
Completion
2026-06-15

Drugs

EvaluationDrugModalityDoseRoute
Subject [ Lu-177]-Catalase Unknown — Other

Indications